Buclizine Hydrochloride 50mg Tablet in PCD pharma franchise in Hyderabad

Buclizine Hydrochloride 50mg Tablet in pharmaceutical manufacturing company in Mumbai

Buclizine Hydrochloride 50mg Tablet in antiemetic pharma franchise in Pune

Buclizine Hydrochloride 50mg Tablet in pharma suppliers in Delhi

Buclizine Hydrochloride 50mg Tablet in pharma export companies in Kolkata
Bucoli 50 Tablet in nausea and vomiting care pharma franchise opportunities in Bengaluru

Home/Products /buclizine-hydrochloride-50mg-tablets

Bucoli 50 Tablet

Composition : Buclizine Hydrochloride 50mg Tablets

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹69/-

Bucoli 50 Tablet contains Buclizine Hydrochloride 50mg, an antihistamine with antiemetic and appetite-stimulating properties. It acts primarily by blocking histamine (H1) receptors in the brain, helping to reduce nausea, dizziness, and motion sickness. Additionally, Buclizine is known to stimulate appetite and weight gain, making it useful in conditions involving anorexia or undernutrition. Its mild sedative effects also contribute to symptom relief in travel-related or inner ear disorders.

Read More

About the Product

Bucoli 50 Tablet contains Buclizine Hydrochloride 50mg, an antihistamine with antiemetic and appetite-stimulating properties. It acts primarily by blocking histamine (H1) receptors in the brain, helping to reduce nausea, dizziness, and motion sickness. Additionally, Buclizine is known to stimulate appetite and weight gain, making it useful in conditions involving anorexia or undernutrition. Its mild sedative effects also contribute to symptom relief in travel-related or inner ear disorders.

Buclizine is generally well tolerated. Some patients may experience drowsiness, dry mouth, blurred vision, or mild dizziness. These effects are typically mild and resolve on their own. Caution is advised when performing tasks that require alertness.

Bucoli 50 is indicated for the management of nausea, vomiting, motion sickness, and vertigo. It is also prescribed as an appetite stimulant in cases of anorexia, malnutrition, and underweight conditions, especially in pediatric or convalescent patients.

Use only as directed by a physician. Not recommended for use in children below the age prescribed by your healthcare provider. Avoid alcohol and CNS depressants while taking this medication. Caution is required in patients with glaucoma, asthma, or urinary retention.

Store in a cool, dry place below 25°C. Protect from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation